Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL) for the Treatment of Advanced Malignant Solid Tumors

Conditions: Solid Tumor; Gynecologic Cancer; Breast Cancer; Gastrointestinal Cancer; Lung Cancer Interventions: Biological: Engineering Tumor Infiltrating Lymphocytes Sponsors: Shanghai Juncell Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials